To easily find benefit details on the plans we offer, visit the plan documents page
The SURMOUNT program (NEJM 2022) studied tirzepatide for weight management, and SURMOUNT-OSA (NEJM 2024) examined it for obstructive sleep apnea
10.1016/0011-393x(95)85135-6 [DOI] [Google Scholar] Yazaki Y., Chow G., Mattie M
Moreover, MRI is contraindicated in certain patient populations, such as those with implanted metal devices or pacemakers
Comparative Affinity: Evaluating Retatrutide in the Context of Modern Incretin Science Explore the scientific differences between Retatrutide, Tirzepatide, and Semaglutide
Fischer GM, Guerrieri RA, Hu Q, Carapeto FC, Joon AY, Gopal VY, Knighton B, Deng W, Haydu LE, Gershenwald JE, Lazar AJ, Tetzlaff MT, Davies MA